Federal Appellate Court Finds Pfizer’s Proposed Copay Assistance Program For Expensive Heart Drug Would Violate Anti-Kickback Statute
Pfizer’s Proposed Copay Assistance Program Violates Anti-Kickback Statute: Pfizer, Inc. produces and sells a drug called tafamidis that treats a rare, progressive heart condition known as transthyretin amyloid cardiomyopathy. Without treatment, patients have a median life expectancy of two to [...]